HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sibutramine-Spiked Supplements: Consumer Health Product Recall News

This article was originally published in The Rose Sheet

Executive Summary

The latest product marketed as a dietary supplement but containing the banned weight loss ingredient sibutramine is A1 Slim, on recall by Kiriko. Three flavors of Jete Nutritional Energy Bar were recalled due to labeling errors, including omitting that sulfites in the products came from Non-GMO apples.

You may also be interested in...



Coconut Probiotic Beverages Recalled Due To Premature Spoilage

Harmless Harvest's recall of a product it launched in January is attributed to premature spoilage and tests identified Candida lusitaniae "as the predominate microorganism as the cause of spoilage," FDA says.

More Ephedra Found, Sibutramine Crime In Texas: Health And Wellness Industry News

MusclMasster recalls Al-Er-G after FDA officials discovered during a recent inspection it contained ephedra. The use of sibutramine in products marketed as supplements led to a Texas man's conviction on a criminal count of possessing a controlled substance.

Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children

Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121241

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel